Healthcare Infection Control Practices Advisory Committee (HICPAC), 506 [2019-28449]
Download as PDF
<![CDATA[
506
Federal Register / Vol. 85, No. 3 / Monday, January 6, 2020 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–28450 Filed 1–3–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). This meeting is open to the
public, limited only by the space
available. The meeting room
accommodates up to 120 people. The
public is also welcome to listen to the
meeting via teleconference at 1–800–
857–2850, passcode: 2622054; 100
teleconference lines are available.
DATES: The meeting will be held on
March 5, 2020, 9:00 a.m. to 5:00 p.m.,
EST, and March 6, 2020, 9:00 a.m. to
12:00 p.m., EST.
ADDRESSES: Centers for Disease Control
and Prevention, Global Communications
Center, Building 19, Auditorium B, 1600
Clifton Road NE, Atlanta, Georgia
30329–4027 and teleconference at 1–
800–857–2850, passcode: 2622054.
FOR FURTHER INFORMATION CONTACT: KooWhang Chung, M.P.H., HICPAC,
Division of Healthcare Quality
Promotion, NCEZID, CDC, l600 Clifton
Road NE, Mailstop H16–3, Atlanta,
Georgia 30329–4027; Telephone: (404)
498–0730; Email: hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION: Time will
be available for public comment. The
public is welcome to submit written
comments in advance of the meeting.
Comments should be submitted in
writing by email to the contact person
listed below. The deadline for receipt of
written public comment is February 20,
2020. All requests must contain the
name, address, and organizational
affiliation of the speaker, as well as the
topic being addressed. Written
comments should not exceed one singlespaced typed page in length and
lotter on DSKBCFDHB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:53 Jan 03, 2020
Jkt 250001
delivered in 3 minutes or less. Members
of the public who wish to provide
public comments should plan to attend
the public comment session at the start
time listed. Please note that the public
comment period may end before the
time indicated, following the last call
for comments. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. Registration is required to
attend in person or on the phone.
Interested parties must be processed in
accordance with established federal
policies and procedures and may
register at https://www.cdc.gov/hicpac.
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, and the Secretary,
Health and Human Services, regarding
(1) the practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Considered: The agenda
will include updates on CDC’s activities
for prevention of healthcare-associated
infections. It will also include updates
from the following HICPAC workgroups:
The Healthcare Personnel Guideline
Workgroup; the Neonatal Intensive Care
Unit (NICU) Guideline Workgroup; the
National Healthcare Safety Network
(NHSN) Workgroup; and the
Bloodstream Infection Workgroup. The
agenda also includes updates on CDC
and DHQP activities. Agenda items are
subject to change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–28449 Filed 1–3–20; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00014
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10237]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
SUMMARY:
Comments on the collection(s) of
information must be received by the
OMB desk officer by February 5, 2020.
ADDRESSES: When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
following transmissions: OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
Number: (202) 395–5806 OR Email:
OIRA_submission@omb.eop.gov.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/
PRA=Listing.html.
DATES:
E:\FR\FM\06JAN1.SGM
06JAN1
]]>Agencies
[Federal Register Volume 85, Number 3 (Monday, January 6, 2020)]
[Notices]
[Page 506]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-28449]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Healthcare Infection Control
Practices Advisory Committee (HICPAC). This meeting is open to the
public, limited only by the space available. The meeting room
accommodates up to 120 people. The public is also welcome to listen to
the meeting via teleconference at 1-800-857-2850, passcode: 2622054;
100 teleconference lines are available.
DATES: The meeting will be held on March 5, 2020, 9:00 a.m. to 5:00
p.m., EST, and March 6, 2020, 9:00 a.m. to 12:00 p.m., EST.
ADDRESSES: Centers for Disease Control and Prevention, Global
Communications Center, Building 19, Auditorium B, 1600 Clifton Road NE,
Atlanta, Georgia 30329-4027 and teleconference at 1-800-857-2850,
passcode: 2622054.
FOR FURTHER INFORMATION CONTACT: Koo-Whang Chung, M.P.H., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton
Road NE, Mailstop H16-3, Atlanta, Georgia 30329-4027; Telephone: (404)
498-0730; Email: [email protected].
SUPPLEMENTARY INFORMATION: Time will be available for public comment.
The public is welcome to submit written comments in advance of the
meeting. Comments should be submitted in writing by email to the
contact person listed below. The deadline for receipt of written public
comment is February 20, 2020. All requests must contain the name,
address, and organizational affiliation of the speaker, as well as the
topic being addressed. Written comments should not exceed one single-
spaced typed page in length and delivered in 3 minutes or less. Members
of the public who wish to provide public comments should plan to attend
the public comment session at the start time listed. Please note that
the public comment period may end before the time indicated, following
the last call for comments. Written comments received in advance of the
meeting will be included in the official record of the meeting.
Registration is required to attend in person or on the phone.
Interested parties must be processed in accordance with established
federal policies and procedures and may register at https://www.cdc.gov/hicpac.
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion
(DHQP), the Director, National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), the Director, CDC, and the Secretary,
Health and Human Services, regarding (1) the practice of healthcare
infection prevention and control; (2) strategies for surveillance,
prevention, and control of infections, antimicrobial resistance, and
related events in settings where healthcare is provided; and (3)
periodic updating of CDC guidelines and other policy statements
regarding prevention of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Considered: The agenda will include updates on CDC's
activities for prevention of healthcare-associated infections. It will
also include updates from the following HICPAC workgroups: The
Healthcare Personnel Guideline Workgroup; the Neonatal Intensive Care
Unit (NICU) Guideline Workgroup; the National Healthcare Safety Network
(NHSN) Workgroup; and the Bloodstream Infection Workgroup. The agenda
also includes updates on CDC and DHQP activities. Agenda items are
subject to change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-28449 Filed 1-3-20; 8:45 am]
BILLING CODE 4163-18-P
